Business Context and Reporting Period
This Form 8-K filing by Anteris Technologies Global Corp. (AVR) reports a material event occurring on July 28, 2025, with the report dated July 29, 2025. The Company, an emerging growth company incorporated in Delaware, operates in the medical technology sector and is listed on The Nasdaq Global Market.
Key Financial Metrics
This filing is a Current Report regarding a material agreement and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Agreements
On July 28, 2025, the Company entered into a First Amended and Restated Master Services Agreement (A&R MSA) with Switchback Medical, LLC. Key terms include:
- Scope: Switchback will provide development and manufacturing services, including engineering and testing, based on purchase orders at set prices per unit.
- Intellectual Property: The Company granted Switchback a limited, exclusive, royalty-free license to certain IP solely for manufacturing purposes. The Company retains all rights to testing data and any newly developed IP.
- Term: The agreement expires on March 31, 2028, with automatic one-year renewals unless terminated by either party at least 180 days prior to the end of the term.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the A&R MSA to secure development and manufacturing capabilities. The filing notes that the summary is qualified by the full text of the agreement, which will be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending September 30, 2025. No specific financial guidance or new risk factors were disclosed in this document.
Investor Verification Checklist
- Verify the specific pricing terms and volume commitments within the full text of the A&R MSA once filed as an exhibit to the 10-Q.
- Confirm the impact of the Switchback agreement on the Company's future cost of goods sold and gross margin projections.
- Review the Company's upcoming 10-Q for the quarter ending September 30, 2025, for detailed financial results and the full agreement text.
- Assess the Company's reliance on Switchback for critical manufacturing and engineering services.